These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1045 related articles for article (PubMed ID: 23642949)

  • 1. A pilot study investigating the effect of Caralluma fimbriata extract on the risk factors of metabolic syndrome in overweight and obese subjects: a randomised controlled clinical trial.
    Astell KJ; Mathai ML; McAinch AJ; Stathis CG; Su XQ
    Complement Ther Med; 2013 Jun; 21(3):180-9. PubMed ID: 23642949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Caralluma fimbriata extract on appetite, food intake and anthropometry in adult Indian men and women.
    Kuriyan R; Raj T; Srinivas SK; Vaz M; Rajendran R; Kurpad AV
    Appetite; 2007 May; 48(3):338-44. PubMed ID: 17097761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of an orally-dosed Caralluma Fimbriata extract on appetite control and body composition in overweight adults.
    Rao A; Briskey D; Dos Reis C; Mallard AR
    Sci Rep; 2021 Mar; 11(1):6791. PubMed ID: 33762661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of metabolic syndrome among Filipino adults aged 20 years and over.
    Tanchoco CC; Cruz AJ; Duante CA; Litonjua AD
    Asia Pac J Clin Nutr; 2003; 12(3):271-6. PubMed ID: 14505989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of sibutramine in obese mexican adolescents: a 6-month, randomized, double-blind, placebo-controlled, parallel-group trial.
    García-Morales LM; Berber A; Macias-Lara CC; Lucio-Ortiz C; Del-Rio-Navarro BE; Dorantes-Alvárez LM
    Clin Ther; 2006 May; 28(5):770-82. PubMed ID: 16861099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coleus forskohlii Extract Supplementation in Conjunction with a Hypocaloric Diet Reduces the Risk Factors of Metabolic Syndrome in Overweight and Obese Subjects: A Randomized Controlled Trial.
    Loftus HL; Astell KJ; Mathai ML; Su XQ
    Nutrients; 2015 Nov; 7(11):9508-22. PubMed ID: 26593941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rye bread enriched with green tea extract on weight maintenance and the characteristics of metabolic syndrome following weight loss: a pilot study.
    Bajerska J; Mildner-Szkudlarz S; Walkowiak J
    J Med Food; 2015 Jun; 18(6):698-705. PubMed ID: 25494205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a proprietary Magnolia and Phellodendron extract on weight management: a pilot, double-blind, placebo-controlled clinical trial.
    Garrison R; Chambliss WG
    Altern Ther Health Med; 2006; 12(1):50-4. PubMed ID: 16454147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of meal replacement on metabolic risk factors in overweight and obese subjects.
    König D; Deibert P; Frey I; Landmann U; Berg A
    Ann Nutr Metab; 2008; 52(1):74-8. PubMed ID: 18319587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of 12 weeks supplementation of a botanical extract-based weight loss formula on body weight, body composition and blood chemistry in healthy, overweight subjects--a randomised double-blind placebo-controlled clinical trial.
    Opala T; Rzymski P; Pischel I; Wilczak M; Wozniak J
    Eur J Med Res; 2006 Aug; 11(8):343-50. PubMed ID: 17052970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a fibre supplement compared to a healthy diet on body composition, lipids, glucose, insulin and other metabolic syndrome risk factors in overweight and obese individuals.
    Pal S; Khossousi A; Binns C; Dhaliwal S; Ellis V
    Br J Nutr; 2011 Jan; 105(1):90-100. PubMed ID: 20727237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of sibutramine in overweight adult hispanic patients with type 2 diabetes mellitus: a 12-month, randomized, double-blind, placebo-controlled clinical trial.
    Sánchez-Reyes L; Fanghänel G; Yamamoto J; Martínez-Rivas L; Campos-Franco E; Berber A
    Clin Ther; 2004 Sep; 26(9):1427-35. PubMed ID: 15531005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second phase of a double-blind study clinical trial on Sibutramine for the treatment of patients suffering essential obesity: 6 months after treatment cross-over.
    Fanghänel G; Cortinas L; Sánchez-Reyes L; Berber A
    Int J Obes Relat Metab Disord; 2001 May; 25(5):741-7. PubMed ID: 11360159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sibutramine on body weight and serum lipids: a double-blind, randomized, placebo-controlled study in 322 overweight and obese patients with dyslipidemia.
    Dujovne CA; Zavoral JH; Rowe E; Mendel CM;
    Am Heart J; 2001 Sep; 142(3):489-97. PubMed ID: 11526363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects.
    Cornelli U; Belcaro G; Cesarone MR; Cornelli M
    Minerva Cardioangiol; 2008 Oct; 56(5 Suppl):71-8. PubMed ID: 19597412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Nigella sativa oil with a low-calorie diet on cardiometabolic risk factors in obese women: a randomized controlled clinical trial.
    Mahdavi R; Namazi N; Alizadeh M; Farajnia S
    Food Funct; 2015 Jun; 6(6):2041-8. PubMed ID: 26029855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexfenfluramine as an adjunct to a reduced-fat, ad libitum diet: effects on body composition, nutrient intake and cardiovascular risk factors.
    Swinburn BA; Carmichael HE; Wilson MR
    Int J Obes Relat Metab Disord; 1996 Nov; 20(11):1033-40. PubMed ID: 8923161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of Caralluma fimbriata as an appetite suppressant and weight loss supplement: a systematic review and meta-analysis of clinical trials.
    Jayawardena R; Francis TV; Abhayaratna S; Ranasinghe P
    BMC Complement Med Ther; 2021 Nov; 21(1):279. PubMed ID: 34758791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of synbiotic supplementation on some cardio-metabolic risk factors in overweight and obese children: a randomized triple-masked controlled trial.
    Safavi M; Farajian S; Kelishadi R; Mirlohi M; Hashemipour M
    Int J Food Sci Nutr; 2013 Sep; 64(6):687-93. PubMed ID: 23477506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Six months supplementation with conjugated linoleic acid induces regional-specific fat mass decreases in overweight and obese.
    Gaullier JM; Halse J; Høivik HO; Høye K; Syvertsen C; Nurminiemi M; Hassfeld C; Einerhand A; O'Shea M; Gudmundsen O
    Br J Nutr; 2007 Mar; 97(3):550-60. PubMed ID: 17313718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.